PSCHInvesco S&P SmallCap Health...


$ 42.53 $ 0.45 (1.07 %)    

Friday, 28-Jun-2024 15:59:45 EDT
QQQ $ 479.98 $ -2.50 (-0.52 %)
DIA $ 391.11 $ -0.43 (-0.11 %)
SPY $ 544.70 $ -2.15 (-0.39 %)
TLT $ 91.77 $ -1.74 (-1.86 %)
GLD $ 215.03 $ 0.02 (0.01 %)
$ 42.6
$ 42.53
$ 0.00 x 0
$ 0.00 x 0
$ 42.53 - $ 42.56
$ 34.62 - $ 45.18
8,953
na
na
$ 0.99
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-is-health-care-company-fortrea-stock-diving-today

Fortrea reported weak Q1 FY24 results and lowered its revenue outlook. Backlog at $7.4B, adjusted EBITDA declined, and EPS missed.

 organon-beats-on-q1-womens-health-leads-the-charge

Organon reported 5% increase in Q1 2024 revenue of $1.622 billion, beating consensus. EPS of $1.22 and dividend of $0.28 declared.